AHL Investment Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-65
Closed -$2K 69
2021
Q4
$2K Buy
+65
New +$1.79K ﹤0.01% 298

Other funds holding ANGO

AHL Investment Management's ANGO Position: Q1 2022 in Review

AHL Investment Management sold out of AngioDynamics (ANGO) in Q1 2022, closing a stake of 65 shares — an estimated $2K sold.

AHL Investment Management first reported a position in ANGO in Q4 2021 and held it in 1 quarter. The position peaked at $2K in Q4 2021. 144 funds tracked by Wall St. Rank hold ANGO as of Q1 2022.

  • AHL Investment Management reported no remaining AngioDynamics position as of Q1 2022 after selling out during the quarter.
  • AHL Investment Management sold 65 AngioDynamics shares in Q1 2022, an estimated $2K.
  • AHL Investment Management first reported a position in AngioDynamics in Q4 2021 and held it in 1 quarter.
  • AHL Investment Management's AngioDynamics position peaked at $2K in Q4 2021.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2022.

Based on AHL Investment Management's 13F filing for Q1 2022, filed 28 Apr 2022.